<!DOCTYPE html>
<html lang="en">
<head>
  <title>Healthcare system</title>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.4.1/css/bootstrap.min.css">
  <script src="https://ajax.googleapis.com/ajax/libs/jquery/3.5.1/jquery.min.js"></script>
  <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.4.1/js/bootstrap.min.js"></script>
  <style>
	body {margin: 1;}
	
	ul.topnav {
	  list-style-type: none;
	  margin: 0;
	  padding: 0;
	  overflow: hidden;
	  background-color: rgb(241, 45, 160);
	}
	
	ul.topnav li {float: left;}
	
	ul.topnav li a {
	  display: block;
	  color: white;
	  text-align: center;
	  padding: 14px 16px;
	  text-decoration: none;
	} 
    ul.topnav li.right {float: right;}
    ul.topnav li.right,
    } 
	
	</style>
</head>
<body style="color: white;background-image: linear-gradient(to top , rgb(240, 6, 185), rgb(158, 6, 75));">
	<ul class="topnav">
		<li><a class="active" href="file:///D:/minor/templates/Index.html">Home</a></li>
		<li><a  href="file:///D:/minor/templates/about.html">About</a></li>
		<li><a href="file:///D:/minor/templates/parkinson.html">Prediction</a></li>
		<li><a href="#disease">Consult doctor</a></li>
		<li class="right"><a href="file:///D:/minor/templates/contact.html">Contact</a></li>
	  </ul>
  
    <!--================End Home Banner Area =================-->

	<!--================ Start About Area =================-->
	
	</section>
	<section class="about_area lite_bg">
		<div class="container">
			<div class="row align-items-center">
				<div class="col-lg-12 row-lg-2">
					<div class="about_details lite_bg">
						<h2>What is Parkinson’s Disease?</h2>
						<p>Involuntary tremulous motion, with lessened muscular power, in parts not in action and even when supported; with a propensity to bend the trunk forward, and to pass from a walking to a running pace: the senses and intellects being uninjured.
						</p>
						
					</div>
				</div>
				
			</div>
			<div class="about_bg2 overlay"></div>
		</div>
	</section>
	<section class="about_area lite_bg">
		<div class="container">
			<div class="row align-items-center">
				<div class="col-lg-12 col-md-5">
					<div class="about_details lite_bg">
						<h2>Easier Explanation:
						</h2>
						<p>Parkinson's disease is a brain disorder that leads to shaking, stiffness, and difficulty with walking, balance, and coordination. 
						
							Parkinson's symptoms usually begin gradually and get worse over time. As the disease progresses, people may have difficulty walking and talking. They may also have mental and behavioural changes, sleep problems, depression, memory difficulties, and fatigue.
							<br>Both men and women can have Parkinson’s disease. However, the disease affects about 50 percent more men than women.
							</p>
						
					</div>
				</div>
		
			</div>
            <center>
			<img src="https://images.emedicinehealth.com/images/slideshow/parkinsons-disease-s1-illustration-of-parkinsons-disease-composite.jpg"width="650" height="400"></center>
			<div class="about_bg2 overlay"></div>
		</div>
	</section>
	<section class="about_area lite_bg">
		<div class="container">
			<div class="row align-items-center">
				<div class="col-lg-12 col-md-5">
					<div class="about_details lite_bg">
						<h2>Early Descriptions:
							</h2>
						<p>Parkinson's disease was first medically described as a neurological syndrome by James Parkinson in 1817, though fragments of Parkinsonism can be found in earlier descriptions (Parkinson 1817). As examples, Sylvius de la Boë wrote of rest tremor, and Sauvages described festination (Sylvius de la Boë 1680; Sauvages 1768; Tyler 1992). Much earlier, traditional Indian texts from approximately 1000 BC and ancient Chinese sources also provide descriptions that suggest Parkinson's disease (Manyam 1990; Zhang et al. 2006).
						</p>
						
					</div>
				</div>
				
			</div>
			<div class="about_bg2 overlay"></div>
		</div>
    </div>
    <center>
			<img src="https://images.everydayhealth.com/images/neurology/parkinsons-disease/recognizing-the-progression-of-parkinsons-722x406.jpg?sfvrsn=fc419326_0"width="650" height="400">
			</center>
            <div class="about_bg2 overlay"></div>
		</div>
	</section>
	<section class="about_area lite_bg">
		<div class="container">
			<div class="row align-items-center">
				<div class="col-lg-12 col-md-5">
					<div class="about_details lite_bg">
						<h2>Age:
						</h2>
						<p>One clear risk factor for Parkinson's is age. Although most people with Parkinson’s first develop the disease at about age 60, about 5 to 10 percent of people with Parkinson's have "early-onset" disease, which begins before the age of 50. Early-onset forms of Parkinson's are often, but not always, inherited, and some forms have been linked to specific gene mutations.
						</p>
						
					</div>
				</div>
				
			</div>
            <center>
			<img src="https://cdn.yashodahospitals.com/wp-content/uploads/parkinson%E2%80%99s-disease.jpg"width="650" height="400">
            </center>
			<div class="about_bg2 overlay"></div>
		</div>
	</section>
	<section class="about_area lite_bg">
		<div class="container">
			<div class="row align-items-center">
				<div class="col-lg-12 col-md-5">
					<div class="about_details lite_bg">
						<h2>What Causes Parkinson's Disease?
						</h2>
						<p>Parkinson's disease occurs when nerve cells, or neurons, in an area of the brain that controls movement become impaired and/or die. Normally, these neurons produce an important brain chemical known as dopamine. When the neurons die or become impaired, they produce less dopamine, which causes the movement problems of Parkinson's. Scientists still do not know what causes cells that produce dopamine to die.
							People with Parkinson's also lose the nerve endings that produce norepinephrine, the main chemical messenger of the sympathetic nervous system, which controls many automatic functions of the body, such as heart rate and blood pressure. The loss of norepinephrine might help explain some of the non-movement features of Parkinson's, such as fatigue, irregular blood pressure, decreased movement of food through the digestive tract, and sudden drop in blood pressure when a person stands up from a sitting or lying-down position.
							Many brain cells of people with Parkinson's contain Lewy bodies, unusual clumps of the protein alpha-synuclein. Scientists are trying to better understand the normal and abnormal functions of alpha-synuclein and its relationship to genetic mutations that impact Parkinson’s disease and Lewy body dementia.
							Although some cases of Parkinson's appear to be hereditary, and a few can be traced to specific genetic mutations, in most cases the disease occurs randomly and does not seem to run in families. Many researchers now believe that Parkinson's disease results from a combination of genetic factors and environmental factors such as exposure to toxins.
							</p>
						
					</div>
				</div>
				
			</div>
			<img src="https://www.narayanahealth.org/blog/wp-content/uploads/2015/04/parkinson.png">
			<div class="about_bg2 overlay"></div>
		</div>
	</section>
</section>
<section class="about_area lite_bg">
	<div class="container">
		<div class="row align-items-center">
			<div class="col-lg-12 col-md-5">
				<div class="about_details lite_bg">
					<h2>Symptoms of Parkinson’s Disease</h2>
					<p>
						Parkinson's disease has four main symptoms:
						<br>1.Tremor (trembling) in hands, arms, legs, jaw, or head
						<br>2.Stiffness of the limbs and trunk
						<br>3.Slowness of movement
						<br>4.Impaired balance and coordination, sometimes leading to falls
						<br><br>Other symptoms may include depression and other emotional changes; difficulty swallowing, chewing, and speaking; urinary problems or constipation; skin problems; and sleep disruptions.
						<br>Symptoms of Parkinson’s and the rate of progression differ among individuals. Sometimes people dismiss early symptoms of Parkinson's as the effects of normal aging. In most cases, there are no medical tests to definitively detect the disease, so it can be difficult to diagnose accurately.
						Early symptoms of Parkinson's disease are subtle and occur gradually. For example, affected people may feel mild tremors or have difficulty getting out of a chair. They may notice that they speak too softly, or that their handwriting is slow and looks cramped or small. Friends or family members may be the first to notice changes in someone with early Parkinson's. They may see that the person's face lacks expression and animation, or that the person does not move an arm or leg normally.
						People with Parkinson's often develop a parkinsonian gait that includes a tendency to lean forward, small quick steps as if hurrying forward, and reduced swinging of the arms. They also may have trouble initiating or continuing movement.
						Symptoms often begin on one side of the body or even in one limb on one side of the body. As the disease progresses, it eventually affects both sides. However, the symptoms may still be more severe on one side than on the other.
						Many people with Parkinson’s note that prior to experiencing stiffness and tremor, they had sleep problems, constipation, decreased ability to smell, and restless legs.
						</p>
					
				</div>
			</div>
			
		</div>
		<img src="https://www.verywellhealth.com/thmb/r4vt8fXUvIahj1BZBKWqra_FolY=/1500x1000/filters:no_upscale():max_bytes(150000):strip_icc()/parkinsonism-causes-symptoms-and-treatment-5189631_final-01-06edf39f8a2a42f59d40151e8dd405b4.jpg" width="100%">
		<div class="about_bg2 overlay"></div>
	</div>
</section>
</section>
<section class="about_area lite_bg">
	<div class="container">
		<div class="row align-items-center">
			<div class="col-lg-12 col-md-5">
				<div class="about_details lite_bg">
					<h2>Diagnosis of Parkinson’s Disease
					</h2>
					<p>A number of disorders can cause symptoms similar to those of Parkinson's disease. People with Parkinson's-like symptoms that result from other causes are sometimes said to have parkinsonism. While these disorders initially may be misdiagnosed as Parkinson's, certain medical tests, as well as response to drug treatment, may help to distinguish them from Parkinson's. Since many other diseases have similar features but require different treatments, it is important to make an exact diagnosis as soon as possible.
						There are currently no blood or laboratory tests to diagnose nongenetic cases of Parkinson's disease. Diagnosis is based on a person's medical history and a neurological examination. Improvement after initiating medication is another important hallmark of Parkinson's disease.
						</p>
					
				</div>
			</div>
			
		</div>
        <center>
		<img src="https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41401-020-0365-y/MediaObjects/41401_2020_365_Fig1_HTML.png"width="650" height="400">
		</center>
        <div class="about_bg2 overlay"></div>
	</div>
</section>
</section>
<section class="about_area lite_bg">
	<div class="container">
		<div class="row align-items-center">
			<div class="col-lg-12 col-md-5">
				<div class="about_details lite_bg">
					<h2>Treatment of Parkinson’s Disease
					</h2>
					<p>Although there is no cure for Parkinson's disease, medicines, surgical treatment, and other therapies can often relieve some symptoms.
					</p>
					
				</div>
			</div>
			
		</div>
		<div class="about_bg2 overlay"></div>
	</div>
</section>
</section>

<section class="about_area lite_bg">
	<div class="container">
		<div class="row align-items-center">
			<div class="col-lg-12 col-md-5">
				<div class="about_details lite_bg">
					<h2>Medicines prescribed for Parkinson's include:</h2>
					<p>Drugs that increase the level of dopamine in the brain
						Drugs that affect other brain chemicals in the body
						Drugs that help control nonmotor symptoms
						The main therapy for Parkinson's is levodopa, also called L-dopa. Nerve cells use levodopa to make dopamine to replenish the brain's dwindling supply. Usually, people take levodopa along with another medication called carbidopa. Carbidopa prevents or reduces some of the side effects of levodopa therapy—such as nausea, vomiting, low blood pressure, and restlessness—and reduces the amount of levodopa needed to improve symptoms.
						People with Parkinson's should never stop taking levodopa without telling their doctor. Suddenly stopping the drug may have serious side effects, such as being unable to move or having difficulty breathing.
						Other medicines used to treat Parkinson’s symptoms include:
						Dopamine agonists to mimic the role of dopamine in the brain
						MAO-B inhibitors to slow down an enzyme that breaks down dopamine in the brain
						COMT inhibitors to help break down dopamine
						Amantadine, an old antiviral drug, to reduce involuntary movements
						Anticholinergic drugs to reduce tremors and muscle rigidity
						</p>
					
				</div>
			</div>
			
		</div>
        <center>
		<img src="https://www.fau.eu/files/2018/07/Parkinson_COLOURBOX14304974.jpg"width="650" height="400">
        </center>
		<div class="about_bg2 overlay"></div>
	</div>
</section>
</section>
<section class="about_area lite_bg">
	<div class="container">
		<div class="row align-items-center">
			<div class="col-lg-12 col-md-5">
				<div class="about_details lite_bg">
					<h2>Deep Brain Stimulation
					</h2>
					<p>For people with Parkinson’s who do not respond well to medications, deep brain stimulation, or DBS, may be appropriate. DBS is a surgical procedure that surgically implants electrodes into part of the brain and connects them to a small electrical device implanted in the chest. The device and electrodes painlessly stimulate the brain in a way that helps stop many of the movement-related symptoms of Parkinson's, such as tremor, slowness of movement, and rigidity.</p>
					
				</div>
			</div>
			
		</div>
        	
		</div>
        <center>
		<img src="https://lsom.uthscsa.edu/neurosurgery/wp-content/uploads/sites/140/2017/10/dbs_brain-300x260.jpg"width="650" height="400">
	    </center>
		<div class="about_bg2 overlay"></div>
	</div>
</section>
</section>
<section class="about_area lite_bg">
	<div class="container">
		<div class="row align-items-center">
			<div class="col-lg-12 col-md-5">
				<div class="about_details lite_bg">
					<h2>Other Therapies
					</h2>
					<p>Other therapies may be used to help with Parkinson's disease symptoms. They include physical, occupational, and speech therapies, which help with gait and voice disorders, tremors and rigidity, and decline in mental functions. Other supportive therapies include a healthy diet and exercises to strengthen muscles and improve balance.
					</p>
					
				</div>
			</div>
			
		</div>
		<div class="about_bg2 overlay"></div>
	</div>
</section>
<section class="about_area lite_bg">
	<div class="container">
		<div class="row align-items-center">
			<div class="col-lg-12 col-md-5">
				<div class="about_details lite_bg">
					<h2>Death Rate:
					</h2>
					<p>In 2016, 6·1 million (95% uncertainty interval [UI] 5·0–7·3) individuals had Parkinson's disease globally, compared with 2·5 million (2·0–3·0) in 1990. This increase was not solely due to increasing numbers of older people, because age-standardised prevalence rates increased by 21·7% (95% UI 18·1–25·3) over the same period (compared with an increase of 74·3%, 95% UI 69·2–79·6, for crude prevalence rates). Parkinson's disease caused 3·2 million (95% UI 2·6–4·0) DALYs and 211 296 deaths (95% UI 167 771–265 160) in 2016. The male-to-female ratios of age-standardised prevalence rates were similar in 2016 (1·40, 95% UI 1·36–1·43) and 1990 (1·37, 1·34–1·40). From 1990 to 2016, age-standardised prevalence, DALY rates, and death rates increased for all global burden of disease regions except for southern Latin America, eastern Europe, and Oceania. In addition, age-standardised DALY rates generally increased across the Socio-demographic Index.</p>
					
				</div>
			</div>
			
		</div>
        <center>
		<img src="data:image/png;base64,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"width="550" height="400">
		</center>
        <div class="about_bg2 overlay"></div>
	</div>
</section>
<section class="about_area lite_bg">
	<div class="container">
		<div class="row align-items-center">
			<div class="col-lg-12 col-md-5">
				<div class="about_details lite_bg">
					<h2>Healthcare system behind Parkinson’s:
					</h2>
					<p><br><h3>Background</h3><br>
						Parkinson's disease (PD) is the second most common chronic neurological disorder of the elderly. Despite the fact that a comprehensive review of general health care in the United States showed that the quality of care delivered to patients usually falls below professional standards, there is limited data on the quality of care for patients with PD.
						<br><br><h3>Methods</h3><br>
						Using the administrative database, the Pacific Northwest Veterans Health Administration (VHA) Data Warehouse, a population of PD patients with encounters from 10/1/98-12/31/04 were identified. A random sample of 350 patient charts underwent further review for diagnostic evaluation. All patients whose records revealed a physician diagnosis of definite or possible Idiopathic Parkinson's (IPD) disease (n = 150) were included in a medical chart review to evaluate adherence to five evidence-based quality of care indicators.
						<br><br><h3>Results</h3><br>
						For those care indicators with good inter-rater reliability, 16.6% of care received by PD patients was adherent for annual depression screening, 23.4% of care was adherent for annual fall screening and, 67.3% of care was adherent for management of urinary incontinence. Patients receiving specialty care were more likely to be adherent with fall screening than those not receiving specialty care OR = 2.3, 95%CI = 1.2–4.2, but less likely to be adherent with management of urinary incontinence, OR = 0.3, 95%CI = 0.1–0.8. Patients receiving care outside the VA system were more likely to be adherent with depression screening OR = 2.4, 95%CI = >1.0–5.5 and fall screening OR = 2.2, 95%CI = 1.1–4.4.
						<br><br><h3>Conclusion</h3><br>
					We found very low rates of adherence for annual screening for depression and falls for PD patients but reasonable adherence rates for management of urinary incontinence. Interestingly, receiving concurrent specialty care did not necessarily result in higher adherence for all care indicators suggesting some coordination and role responsibility confusion. The increased adherence in PD patients receiving care outside the VA system suggests that patients with outside care may demand better care within the VA system.
						</p>
					
				</div>
			</div>
			
		</div>
		<div class="about_bg2 overlay"></div>
	</div>
	
</section>

	<!--================ End About Area =================-->


    <!--================ Start footer Area  =================-->
    <footer class="footer-area section-gap">
		<div class="footer_top section_gap">
			<div class="container">
				<div class="row">
					<div class="col-lg-4 col-md-7 col-sm-8">
						<div class="single-footer-widget">
							<h4 class="text-white">Admin</h4>
							<p class="names">
							
								Adarsh kumar<br>
				               <a href="mailto:adarshkumar1505@gmail.com">adarshkumar1505@gmail.com</a>
								
							
								
							</p>
						</div>
					</div>
					
					<div class="col-lg-4 col-md-6 col-sm-6">
						<div class="single-footer-widget">
							<h4 class="text-white">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Admin</h4>
							<p class="email">
								
								&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Baibhav<br>
							
								&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="mailto:baibhav@gmail.com">baibhav@gmail.com </a>
							</p>
						</div>
					</div>
						</div>
					</div>
				</div>

			</div>
		</div>
		<div class="footer-bottom">
			<div class="container">
				<div class="d-flex justify-content-between align-items-center flex-wrap">
					<p class="footer-text" >
                    Copyright | All rights reserved | ADARSH_&_BAIBHAV

					<div class="footer-social d-flex align-items-center">
						<a href="#"><i class="fa fa-facebook"></i></a>
						<a href="#"><i class="fa fa-twitter"></i></a>
						<a href="#"><i class="fa fa-instagram"></i></a>
					</div>
				</div>
			</div>
		</div>
	</footer
	<!--================ End footer Area  =================-->


	<!-- Additional JavaScript -->
	<!-- jQuery first, then Popper.js, then Bootstrap JS -->
	<script src="js/jquery-3.2.1.min.js"></script>
	<script src="js/popper.js"></script>
	<script src="js/bootstrap.min.js"></script>
	<script src="js/stellar.js"></script>
	<script src="vendors/lightbox/simpleLightbox.min.js"></script>
	<script src="vendors/nice-select/js/jquery.nice-select.min.js"></script>
	<script src="vendors/owl-carousel/owl.carousel.min.js"></script>
	<script src="js/jquery.ajaxchimp.min.js"></script>
	<script src="vendors/counter-up/jquery.waypoints.min.js"></script>
	<script src="vendors/counter-up/jquery.counterup.js"></script>
	<script src="js/mail-script.js"></script>
	<!--gmaps Js-->
	<script src="https://maps.googleapis.com/maps/api/js?key=AIzaSyCjCGmQ0Uq4exrzdcL6rvxywDDOvfAu6eE"></script>
	<script src="js/gmaps.min.js"></script>
	<script src="js/theme.js"></script>
</body>

</html>